Literature DB >> 7118845

The effects of doxepin HCl on sleep and depression.

T Roth, F Zorick, R Wittig, A McLenaghan, T Roehrs.   

Abstract

The effects of doxepin hydrochloride (Adapin) on sleep and depression were evaluated in nine depressed patients with documented sleep difficulties. All subjects were screened for depression on the Hamilton Psychiatric Rating Scale. Sleep disturbance was measured by all-night polysomnography. Doxepin in doses of 75 and 150 mg/day significantly improved sleep efficiency, as evidenced by decreased sleep latency and increased total sleep time. After 2 weeks of treatment, REM latency and percent REM time were dramatically changed. Maximal improvement in depression occurred after 2 weeks of doxepin therapy and at the 150 mg dose.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118845

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  10 in total

1.  Antidepressant and Antipsychotic Drugs.

Authors:  Andrew D Krystal
Journal:  Sleep Med Clin       Date:  2010-12-01

2.  Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder.

Authors:  Jennifer L Vande Voort; Elizabeth D Ballard; David A Luckenbaugh; Rebecca A Bernert; Erica M Richards; Mark J Niciu; Lawrence T Park; Rodrigo Machado-Vieira; Wallace C Duncan; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2017 Sep/Oct       Impact factor: 4.384

3.  Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.

Authors:  Andrew D Krystal; Alan Lankford; H Heith Durrence; Elizabeth Ludington; Philip Jochelson; Roberta Rogowski; Thomas Roth
Journal:  Sleep       Date:  2011-10-01       Impact factor: 5.849

4.  Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.

Authors:  Andrew D Krystal; H Heith Durrence; Martin Scharf; Philip Jochelson; Roberta Rogowski; Elizabeth Ludington; Thomas Roth
Journal:  Sleep       Date:  2010-11       Impact factor: 5.849

Review 5.  Psychiatric disorders and sleep.

Authors:  Andrew D Krystal
Journal:  Neurol Clin       Date:  2012-11       Impact factor: 3.806

6.  Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?

Authors:  Alexandre Y Dombrovski; Jill M Cyranowski; Benoit H Mulsant; Patricia R Houck; Daniel J Buysse; Carmen Andreescu; Michael E Thase; Alan G Mallinger; Ellen Frank
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

Review 7.  Rapid eye movement sleep and sleep continuity. Depression and antidepressants.

Authors:  A N Nicholson; P A Pascoe
Journal:  Drugs       Date:  1989       Impact factor: 9.546

8.  Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.

Authors:  Thomas Roth; Roberta Rogowski; Steven Hull; Howard Schwartz; Gail Koshorek; Bruce Corser; David Seiden; Alan Lankford
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

9.  Modulation of sleep by trimipramine in man.

Authors:  A N Nicholson; P A Pascoe; C Turner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

10.  Efficacy and safety evaluation of citalopram and doxepin on sleep quality in comorbid insomnia and anxiety disorders.

Authors:  Junfeng Wu; Fei Chang; Hengbing Zu
Journal:  Exp Ther Med       Date:  2015-08-17       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.